Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 7Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Leukemia, Myeloid, Acute 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Recurrence 13Multiple Myeloma 12Lymphoma, B-Cell 12Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 8Ovarian Neoplasms 7Lymphoma 7Burkitt Lymphoma 7Melanoma 5Lymphoma, Mantle-Cell 5Hematologic Neoplasms 5Nasopharyngeal Carcinoma 4Myelodysplastic Syndromes 4Lymphoma, T-Cell 4Leukemia 3Graft vs Host Disease 3Uterine Cervical Neoplasms 2Sarcoma, Synovial 2Neuroblastoma 2Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, T-Cell 2Hodgkin Disease 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Temozolomide 44Radiotherapy 16Bevacizumab 9Surgical Procedures, Operative 5Carmustine 5pembrolizumab 4Lomustine 4Drug Therapy 4Sunitinib 3Standard of Care 3Radiation 3Procarbazine 3Irinotecan 3Granulocyte-Macrophage Colony-Stimulating Factor 3Chlorotoxin 3Carboplatin 3Blood Specimen Collection 3tislelizumab 2fludarabine 2camrelizumab 2Radiosurgery 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Hyperbaric Oxygenation 2Ethanol 2Cyclophosphamide 2Chemotherapy, Adjuvant 2CT-322 2Bortezomib 2Aminolevulinic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × fludarabine × Clear all
NCT02937844 2016-10-19

Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme

Beijing Sanbo Brain Hospital

Phase 1 Unknown
20 enrolled
CNS

Glioblastoma

NCT02844062 2016-07-26

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Beijing Sanbo Brain Hospital

Phase 1 Unknown
20 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡